Hazel Davidson‐Smith

716 total citations
9 papers, 496 citations indexed

About

Hazel Davidson‐Smith is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Hazel Davidson‐Smith has authored 9 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in Hazel Davidson‐Smith's work include Epigenetics and DNA Methylation (3 papers), Cystic Fibrosis Research Advances (3 papers) and Tracheal and airway disorders (2 papers). Hazel Davidson‐Smith is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Cystic Fibrosis Research Advances (3 papers) and Tracheal and airway disorders (2 papers). Hazel Davidson‐Smith collaborates with scholars based in United Kingdom, Germany and Switzerland. Hazel Davidson‐Smith's co-authors include David J. Porteous, Gerry McLachlan, Uwe Michaelis, Kurt Naujoks, A D Carothers, Ling‐Pei Ho, A P Greening, Silvia Mora-Lee, M. Imrie and Julia R. Dorin and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Oncogene.

In The Last Decade

Hazel Davidson‐Smith

9 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hazel Davidson‐Smith United Kingdom 7 349 176 123 53 42 9 496
Jenny L. Kerschner United States 16 463 1.3× 133 0.8× 256 2.1× 14 0.3× 51 1.2× 32 682
Rosalie Maurisse France 10 369 1.1× 98 0.6× 61 0.5× 20 0.4× 13 0.3× 17 452
AW Cuthbert United Kingdom 7 273 0.8× 182 1.0× 203 1.7× 65 1.2× 76 1.8× 8 494
P Sinibaldi Italy 7 273 0.8× 156 0.9× 93 0.8× 10 0.2× 7 0.2× 14 458
Maribeth Cherry United States 7 263 0.8× 208 1.2× 31 0.3× 50 0.9× 11 0.3× 7 446
Inna Uliyakina Portugal 12 334 1.0× 41 0.2× 300 2.4× 20 0.4× 8 0.2× 13 625
Chantelle McIntyre Australia 14 200 0.6× 197 1.1× 74 0.6× 47 0.9× 27 0.6× 18 411
Venkateshwar Mutyam United States 10 333 1.0× 67 0.4× 300 2.4× 7 0.1× 24 0.6× 14 583
Diane E. Grove United States 9 308 0.9× 103 0.6× 377 3.1× 14 0.3× 9 0.2× 16 620

Countries citing papers authored by Hazel Davidson‐Smith

Since Specialization
Citations

This map shows the geographic impact of Hazel Davidson‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel Davidson‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel Davidson‐Smith more than expected).

Fields of papers citing papers by Hazel Davidson‐Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazel Davidson‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel Davidson‐Smith. The network helps show where Hazel Davidson‐Smith may publish in the future.

Co-authorship network of co-authors of Hazel Davidson‐Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Hazel Davidson‐Smith. A scholar is included among the top collaborators of Hazel Davidson‐Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazel Davidson‐Smith. Hazel Davidson‐Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gautier, Philippe, Hannah Wapenaar, Hazel Davidson‐Smith, et al.. (2024). DNMT3B PWWP mutations cause hypermethylation of heterochromatin. EMBO Reports. 25(3). 1130–1155. 6 indexed citations
2.
Higham, Jonathan, Hazel Davidson‐Smith, Richard Clark, et al.. (2021). De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands. Nature Communications. 12(1). 694–694. 31 indexed citations
3.
Gong, Chun, Lara J. Monteiro, Ana Gomes, et al.. (2014). FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer. Oncogene. 34(39). 5012–5024. 32 indexed citations
4.
Bradshaw, Nicholas J., Dinesh C. Soares, Becky C. Carlyle, et al.. (2011). PKA Phosphorylation of NDE1 Is DISC1/PDE4 Dependent and Modulates Its Interaction with LIS1 and NDEL1. Journal of Neuroscience. 31(24). 9043–9054. 67 indexed citations
5.
Boyd, A. Christopher, Uwe Michaelis, Heather Davidson, et al.. (1999). Insertion of natural intron 6a‐6b into a human cDNA‐derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination. The Journal of Gene Medicine. 1(5). 312–321. 14 indexed citations
6.
Boyd, Alan, et al.. (1999). pSURF-2, A Modified BAC Vector for Selective YAC Cloning and Functional Analysis. BioTechniques. 27(1). 164–175. 3 indexed citations
7.
Porteous, David J., Gerry McLachlan, Hazel Davidson‐Smith, et al.. (1997). Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy. 4(3). 210–218. 236 indexed citations
8.
McLachlan, Gerry, Ling‐Pei Ho, Hazel Davidson‐Smith, et al.. (1996). Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP.. PubMed. 3(12). 1113–23. 54 indexed citations
9.
McLachlan, Gerry, Donald J. Davidson, Barbara Stevenson, et al.. (1995). Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy.. PubMed. 2(9). 614–22. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026